Search

everythinglearnresearchcommunity

for

Search:↓

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

The new system helps detect and track early female hair loss better.

Fibrosing alopecia can be diagnosed without typical signs of lichen planopilaris.

FFA has higher long-term remission rates than LPP.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

GLPLS and LPP are variants of lichen planus.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Dermoscopes help tell FPHL apart from other hair loss types and can detect it early by identifying specific patterns.

Patients often overestimate their skin type, affecting sun protection and treatment plans.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Female pattern hair loss is common, worsens with age, and requires long-term treatment to manage.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Two main types of fibroblasts with unique functions and additional subtypes were identified in human skin.

Combining different treatments works best for female hair loss.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

FFA and FAPD might be related or stages of the same disease.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

CTE and FPHL are different hair loss types with unique causes.